Your browser doesn't support javascript.
loading
High susceptibility to fatty liver disease in two-pore channel 2-deficient mice.
Grimm, Christian; Holdt, Lesca M; Chen, Cheng-Chang; Hassan, Sami; Müller, Christoph; Jörs, Simone; Cuny, Hartmut; Kissing, Sandra; Schröder, Bernd; Butz, Elisabeth; Northoff, Bernd; Castonguay, Jan; Luber, Christian A; Moser, Markus; Spahn, Saskia; Lüllmann-Rauch, Renate; Fendel, Christina; Klugbauer, Norbert; Griesbeck, Oliver; Haas, Albert; Mann, Matthias; Bracher, Franz; Teupser, Daniel; Saftig, Paul; Biel, Martin; Wahl-Schott, Christian.
Afiliación
  • Grimm C; Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany.
  • Holdt LM; 1] Institute of Laboratory Medicine-University Hospital Munich, 81377 Munich, Germany [2].
  • Chen CC; 1] Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany [2].
  • Hassan S; 1] Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany [2].
  • Müller C; Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 München, Germany.
  • Jörs S; 2nd Department of Internal Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675 München, Germany.
  • Cuny H; 1] Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany [2] [3].
  • Kissing S; Institute of Biochemistry, Christian-Albrechts-Universität Kiel, 24118 Kiel, Germany.
  • Schröder B; Institute of Biochemistry, Christian-Albrechts-Universität Kiel, 24118 Kiel, Germany.
  • Butz E; Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany.
  • Northoff B; Institute of Laboratory Medicine-University Hospital Munich, 81377 Munich, Germany.
  • Castonguay J; Institute for Experimental and Clinical Pharmacology and Toxicology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
  • Luber CA; 1] Max-Planck-Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany [2].
  • Moser M; Max-Planck-Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.
  • Spahn S; Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany.
  • Lüllmann-Rauch R; Institute of Anatomy, Christian-Albrechts-Universität Kiel, 24098 Kiel, Germany.
  • Fendel C; Institute for Cell Biology, Rheinische Friedrich-Wilhelms-Universität Bonn, 53121 Bonn, Germany.
  • Klugbauer N; Institute for Experimental and Clinical Pharmacology and Toxicology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
  • Griesbeck O; Max-Planck-Institute of Neurobiology, Am Klopferspitz 18, 82152 Martinsried, Germany.
  • Haas A; Institute for Cell Biology, Rheinische Friedrich-Wilhelms-Universität Bonn, 53121 Bonn, Germany.
  • Mann M; Max-Planck-Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.
  • Bracher F; Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 München, Germany.
  • Teupser D; Institute of Laboratory Medicine-University Hospital Munich, 81377 Munich, Germany.
  • Saftig P; Institute of Biochemistry, Christian-Albrechts-Universität Kiel, 24118 Kiel, Germany.
  • Biel M; Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany.
  • Wahl-Schott C; Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität, 81377 München, Germany.
Nat Commun ; 5: 4699, 2014 Aug 21.
Article en En | MEDLINE | ID: mdl-25144390
ABSTRACT
Endolysosomal organelles play a key role in trafficking, breakdown and receptor-mediated recycling of different macromolecules such as low-density lipoprotein (LDL)-cholesterol, epithelial growth factor (EGF) or transferrin. Here we examine the role of two-pore channel (TPC) 2, an endolysosomal cation channel, in these processes. Embryonic mouse fibroblasts and hepatocytes lacking TPC2 display a profound impairment of LDL-cholesterol and EGF/EGF-receptor trafficking. Mechanistically, both defects can be attributed to a dysfunction of the endolysosomal degradation pathway most likely on the level of late endosome to lysosome fusion. Importantly, endolysosomal acidification or lysosomal enzyme function are normal in TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic cholesterol overload and liver damage consistent with non-alcoholic fatty liver hepatitis. These findings indicate reduced metabolic reserve of hepatic cholesterol handling. Our results suggest that TPC2 plays a crucial role in trafficking in the endolysosomal degradation pathway and, thus, is potentially involved in the homoeostatic control of many macromolecules and cell metabolites.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Canales de Calcio / Hígado Graso Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Canales de Calcio / Hígado Graso Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania